23.14
-0.27 (-1.13%)
| Penutupan Terdahulu | 23.41 |
| Buka | 23.72 |
| Jumlah Dagangan | 33,263 |
| Purata Dagangan (3B) | 94,724 |
| Modal Pasaran | 453,809,760 |
| Harga / Pendapatan (P/E TTM) | 72.31 |
| Harga / Pendapatan (P/E Ke hadapan) | 66.23 |
| Harga / Jualan (P/S) | 10.50 |
| Harga / Buku (P/B) | 7.03 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Mar 2026 |
| Margin Keuntungan | 9.01% |
| Margin Operasi (TTM) | 4.99% |
| EPS Cair (TTM) | 0.220 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 26.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 897.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.73% |
| Nisbah Semasa (MRQ) | 5.03 |
| Aliran Tunai Operasi (OCF TTM) | 12.13 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 3.66 M |
| Pulangan Atas Aset (ROA TTM) | 1.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 7.41% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Brainsway Ltd. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.13 |
|
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 6.40% |
| % Dimiliki oleh Institusi | 32.27% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Valor Management Llc | 31 Dec 2025 | 2,657,475 |
| Huntleigh Advisors, Inc. | 31 Dec 2025 | 87,076 |
| Julat 52 Minggu | ||
| Median | 30.00 (29.65%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 26 Jan 2026 | 30.00 (29.65%) | Beli | 12.36 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Jan 2026 | Pengumuman | BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™ |
| 12 Jan 2026 | Pengumuman | BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) |
| 07 Jan 2026 | Pengumuman | BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ |
| 22 Dec 2025 | Pengumuman | BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™ |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |